정밀진단 시장(2026-2030년)

The global precision diagnostics market is forecasted to grow by USD 13610.0 mn during 2025-2030, accelerating at a CAGR of 12.1% during the forecast period. The report on the global precision diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapid technological advancements in next-generation sequencing and molecular analysis, escalating global burden of oncology and complex chronic pathologies, integration of ai and ml in diagnostic workflows.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global precision diagnostics market is segmented as below:

By Technology

• Next-generation sequencing
• PCR and qPCR
• Liquid biopsy
• Microarrays
• Others

By Application

• Oncology
• Cardiovascular diseases
• Infectious diseases
• Neurological disorders
• Others

By End-User

• Hospitals and diagnostic laboratories
• Pharmaceutical and biotechnology companies
• Academic and research institutes
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rising prominence of liquid biopsy for longitudinal patient monitoring and early detection as one of the prime reasons driving the global precision diagnostics market growth during the next few years. Also, convergence of multi-omics data and ai to create comprehensive patient digital twins and decentralization of precision tools through advanced point-of-care molecular diagnostic platforms will lead to sizable demand in the market.

The report on the global precision diagnostics market covers the following areas:

• Global precision diagnostics market sizing
• Global precision diagnostics market forecast
• Global precision diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global precision diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., GE HealthCare Technologies, Guardant Health Inc., Illumina Inc., Koninklijke Philips NV, Laboratory Holdings Inc., Myriad Genetics Inc., Oxford Nanopore Technologies, QIAGEN N.V., Quest Diagnostics Inc., Revvity Inc., Siemens Healthineers AG, SOPHiA GENETICS, Sysmex Corp., Thermo Fisher Scientific Inc.. Also, the global precision diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Precision Diagnostics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Precision Diagnostics Market 2020 - 2024 ($ million)
• 5.2 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Precision Diagnostics Market
• 6.2 Impact of geopolitical conflicts on Global Precision Diagnostics Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Technology

• 8.1 Market segments
• 8.2 Comparison by Technology
• 8.3 Next-generation sequencing - Market size and forecast 2025-2030
• 8.4 PCR and qPCR - Market size and forecast 2025-2030
• 8.5 Liquid biopsy - Market size and forecast 2025-2030
• 8.6 Microarrays - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Oncology - Market size and forecast 2025-2030
• 9.4 Cardiovascular diseases - Market size and forecast 2025-2030
• 9.5 Infectious diseases - Market size and forecast 2025-2030
• 9.6 Neurological disorders - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals and diagnostic laboratories - Market size and forecast 2025-2030
• 10.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
• 10.5 Academic and research institutes - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
  • 12.5.7 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 Brazil - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rapid technological advancements in next-generation sequencing and molecular analysis
  • Escalating global burden of oncology and complex chronic pathologies
  • Integration of AI and ML in diagnostic workflows
• 13.2 Market challenges
  • Regulatory complexity and inconsistent reimbursement frameworks
  • Data Privacy concerns and vulnerability of genomic information
  • High implementation costs and shortage of specialized personnel
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rising prominence of liquid biopsy for longitudinal patient monitoring and early detection
  • Convergence of multi-omics data and AI to create comprehensive patient digital twins
  • Decentralization of precision tools through advanced point-of-care molecular diagnostic platforms

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.6 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.7 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.8 GE HealthCare Technologies
  • GE HealthCare Technologies - Overview
  • GE HealthCare Technologies - Business segments
  • GE HealthCare Technologies - Key news
  • GE HealthCare Technologies - Key offerings
  • GE HealthCare Technologies - Segment focus
  • SWOT
• 15.9 Guardant Health Inc.
  • Guardant Health Inc. - Overview
  • Guardant Health Inc. - Product / Service
  • Guardant Health Inc. - Key offerings
  • SWOT
• 15.10 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 15.11 Laboratory Holdings Inc.
  • Laboratory Holdings Inc. - Overview
  • Laboratory Holdings Inc. - Business segments
  • Laboratory Holdings Inc. - Key offerings
  • Laboratory Holdings Inc. - Segment focus
  • SWOT
• 15.12 Oxford Nanopore Technologies
  • Oxford Nanopore Technologies - Overview
  • Oxford Nanopore Technologies - Product / Service
  • Oxford Nanopore Technologies - Key offerings
  • SWOT
• 15.13 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.14 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.15 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.16 SOPHiA GENETICS
  • SOPHiA GENETICS - Overview
  • SOPHiA GENETICS - Product / Service
  • SOPHiA GENETICS - Key offerings
  • SWOT
• 15.17 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key news
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations